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Abstract
Background: The role of HNF4α has been extensively studied in hepatocytes and pancreatic β-
cells, and HNF4α is also regarded as a key regulator of intestinal epithelial cell differentiation. The
aim of the present work is to identify novel HNF4α target genes in the human intestinal epithelial
cells in order to elucidate the role of HNF4α in the intestinal differentiation progress.
Methods: We have performed a ChIP-chip analysis of the human intestinal cell line Caco-2 in
order to make a genome-wide identification of HNF4α binding to promoter regions. The HNF4α
ChIP-chip data was matched with gene expression and histone H3 acetylation status of the
promoters in order to identify HNF4α binding to actively transcribed genes with an open
chromatin structure.
Results:  1,541 genes were identified as potential HNF4α targets, many of which have not
previously been described as being regulated by HNF4α. The 1,541 genes contributed significantly
to gene ontology (GO) pathways categorized by lipid and amino acid transport and metabolism. An
analysis of the homeodomain transcription factor Cdx-2 (CDX2), the disaccharidase trehalase
(TREH), and the tight junction protein cingulin (CGN) promoters verified that these genes are
bound by HNF4α in Caco2 cells. For the Cdx-2 and trehalase promoters the HNF4α binding was
verified in mouse small intestine epithelium.
Conclusion:  The HNF4α regulation of the Cdx-2 promoter unravels a transcription factor
network also including HNF1α, all of which are transcription factors involved in intestinal
development and gene expression.
Background
The intestinal epithelium continuously renews its cells by
division of a stem/progenitor cell population located in
the crypts. The daughter cells rapidly expand by cell divi-
sions and migrate from the crypt to villus. The cells finally
differentiate into the mature cell types of the intestine. In
the small intestine these cells are enterocytes, paneth cells,
goblet cells, and enteroendocrine cells. In the colon two
major cell types predominate: colonocytes and goblet
cells. The differentiation state of the intestinal cells can be
determined by their location on the crypt/villus axis. Cells
located in the bottom of the crypts are undifferentiated
and proliferate (except for the paneth cells, which are
located in the very bottom of the crypt). The cells located
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in the upper crypt and on the villus are differentiated and
express digestive enzymes, transport proteins, mucins, or
hormones, depending on the cell type.
The differentiation process of the intestinal epithelium is
highly organised and regulated at the transcriptional level
[1]. A few transcription factors regulating the differentia-
tion-dependent transcription have been described. Cdx-2
is a homeodomain transcription factor, which in the adult
mouse is only expressed in the intestine [2], and has been
reported to regulate the expression of several intestinal
specific genes, like lactase-phlorizin hydrolase (LCT)[3],
sucrase-isomaltase (SI) [4], calbindin D9k (S100G) [5,6],
hephaestin (HEPH) [7], IL-Cadherin (CDH17) [8], and
phospholipase (PLA2G12B) [9]. Inactivation of the Cdx-2
gene results in an inability of the epithelial cells to differ-
entiate [10], and overexpression can force the undifferen-
tiated intestinal cell line IEC-6 [11] to differentiate.
HNF1α has also been found to regulate several intestinal-
specific genes often in combination with Cdx-2 [9,12-
15,15-18], but inactivation of the HNF1α gene in trans-
genic mice only causes minor changes in the intestinal
transcription.) [19]. GATA-factors seem to be important
regulators of the longitudinal expression pattern of some
genes [13,15,18,20-25]. HNF4α is another transcription
factor expressed in the intestine. HNF4α has been shown
to be important for hepatic epithelium development [26].
Conditional inactivation of HNF4α gene in the colon in
mice resulted in a failure to develop crypts, and a series of
intestinal expressed genes were affected by the lack of
HNF4α expression [27].
We have suggested that HNF4α is a main player in the
transcriptional regulation of the small intestinal differen-
tiation-dependent expression in mice, as promoters for
genes that are up-regulated during the enterocyte differen-
tiation have an over-representation of HNF4α sites in
their promoters [28,29]. In the intestinal epithelium
HNF4α is expressed along the entire length of the crypt
villus axis except in the very bottom of the crypt, and it is
therefore unlikely that HNF4α alone is responsible for the
spatial restriction of gene expression to villus enterocytes
[28,29]. Furthermore, it has been shown that HNF4α pro-
motes differentiation of intestinal epithelial cells in a coc-
ulture system [30]. The HNF4α activity has been reported
to be regulated on several different levels. CREB-binding
protein (CBP) possesses an intrinsic acetyltransferase
activity capable of acetylating HNF4α on lysine residues
within the nuclear localization sequence. CBP-mediated
acetylation increases the nuclear retention and the DNA
binding activity of HNF4α, which increases the target gene
activation by HNF4α [31]. It has also been reported that
the expression or the activity of HNF4α can be modulated
by signaling kinase activities like PKA [32], MAP kinase
[33], and AMP-activated protein kinase [34]. Further-
more, several different isoforms are produced from the
HNF4α gene by different promoter usage and 3'-end splic-
ing codes [35]. Very little is known about the develop-
mental and physiological relevance of the HNF4α
isoforms.
To address the role of HNF4α for the differentiation-
dependent transcription in human epithelial cells, we per-
formed a genome-wide identification of promoters that
are occupied by HNF4α in vivo in Caco-2 cells by the chro-
matin immunoprepitation followed by a DNA promoter
array analysis (ChIP-chip analysis). The ChIP-chip analy-
sis revealed that HNF4α is likely to be associated with the
promoter regions of more than a thousand genes, which
are mainly involved in transport and metabolism. New
and interesting transcription factor networks were
revealed by the analysis, most notably that HNF4α is
found to regulate the expression of Cdx-2, and a model is
proposed in which HNF4α initiates the differentiation-
dependent transcription by simultaneously activating
HNF1α and Cdx-2, transcription factors necessary for the




All primers used in this study were purchased from MWG
Biotech. The primers in additional file 1 were used to
amplify the following promoter sequences from Human
Genomic DNA (Roche): CDX2  (GenBank no.
NM_001265) position -1212 to +36. CGN (GenBank no.
NM_020770) position -1343 to +25. TREH (GenBank no.
NM_007180) position -558 to +84. For each promoter the
PCR product was TA cloned in pCR®2.1 (Invitrogen). The
cloned PCR fragment was cloned into pGL4.10 (Promega)
using the XhoI and HindIII or BglII sites introduced by the
primers. Site-directed mutagenesis was done with all three
plasmids to generate the corresponding promoter plas-
mids containing a mutated HNF4α binding site. The PCR
product was cloned into the original plasmid replacing
the wild-type sequence using the XhoI and HindIII or BglII
sites. The primers used are listed in additional file 1. All
the constructed plasmids were sequenced and analyzed
on an ABI 3100 sequencer (Applied Biosystems).
Cell cultures and transfections
Caco-2 and COS7 cells were cultured as monolayer on
normal cell culture dishes in Dulbecco minimal essential
medium containing 10% fetal calf serum and 100 μg/ml
each of penicillin and streptomycin in a humidified
atmosphere containing 5% CO. The media was changed
twice a week. Caco-2 and COS7 cells were plated one day
before transfection in 24-well plates (5 × 104 cells/well).
The cells were transfected using 5 μL 5.47 mmol/L linear
polyethylenimine (Exgen500; Fermentas) and 0.3 μg plas-BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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mid per well. A total of 50 ng of luciferase reporter plas-
mid and 12.5 ng of β-galactosidase expression plasmid
(pCMVlacZ, Promega) were used in each transfection. The
DNA concentrations were adjusted to 0.3 μg with pBlue-
script SK+ (Stratagene). The cells were harvested and ana-
lyzed two days after transfection for luciferase and β-
galactosidase activity using the Dual Light system
(Applied Biosystems). The luciferase measurements were
normalized and corrected for transfection efficiencies
using the β-galactosidase activities.
RNA extraction and GeneChip hybridization
Total RNA was harvested from undifferentiated preconflu-
ent Caco-2 cells and from differentiated Caco-2 cells (10
days after confluence) using the RNeasy kit (Qiagen).
Biotin labelled cRNA was prepared as previously
described [28] and hybridized to the Human Genome
U133 Plus 2.0 Array (Affymetrix). Three independent
GenecChip hybridisations were performed with RNA
from both undifferentiated and differentiated Caco-2
cells. GeneChip data were analyzed by the robust multi-
array analysis (RMA) procedure [37] using the implemen-
tation of RMA provided by the open source bioconductor
project http://www.bioconductor.org[38]. The gene
expression data is available at NCBI's GEO http://
www.ncbi.nlm.nih.gov/sites/entrez?db=gds under the
series accession number: GSE7745.
Western blot
Western blot analyses were performed by separating
nuclear extracts prepared as described in [39] from undif-
ferentiated pre-confluent and differentiated 10-days post-
confluent Caco-2 cells on a NuPAGE 12% Bis-Tris gel
(Invitrogen). After electrophoresis, the gel was electro-
transfered onto Immobilon membrane (Millipore).
Immunoblotting of HNF4α was performed using 30 μg
protein of Caco-2 nuclear extracts and a 100-fold dilution
of HNF4α antibody sc-8987 (Santa Cruz). Immunoblot-
ting of glyceraldehyde-3-phosphate dehydrogenase
(GAPD) was performed using 10 μg protein of Caco-2
nuclear extracts and 1000× fold dilution of GAPD anti-
body(Chemicon). The blot was developed using the ECL
kit (Amersham Biosciences) and chemiluminescence sig-
nals were captured using a LAS-1000+ (Fujifilm).
Chromatin immunoprecipitation (ChIP) assay
Crosslinking and sonication
Caco-2 cells were cultured as described above until 10
days after confluence. At that stage the Caco-2 cells are
expressing markers of the differentiated enterocyte, e.g.
lactase phlorizin hydrolase [40]. Formaldehyde (Merck)
was added to the culture medium to a final concentration
of 1%. Cross-linking was allowed to proceed for 30 min-
utes at room temperature and stopped by addition of gly-
cine to a final concentration of 0.125 M. This was
followed by an additional incubation for five minutes.
Fixed cells were rinsed twice with cold PBS (137 mM
NaCl, 2.7 mM KCl, 43 mM Na2HPO4·7H2O, 1.4 mM
KH2PO4 and 1 μl/ml protease inhibitors (Sigma Aldrich))
and harvested in cold PBS containing protease inhibitors.
Cells were pelleted by centrifugation and resuspended in
6 ml SDS buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl
pH 8.0, and protease inhibitors). Cells were disrupted by
sonication with a Branson Digital Sonifier 450, at 50%
output for 15 seconds, followed by 30 seconds' resting
time. This was repeated six times, yielding genomic DNA
fragments with an average size of 500 bp.
Adult female mice were sacrificed by cervical dislocation.
The small intestine was rapidly dissected. Small intestinal
mucosa was scraped off with a microscope slide and fro-
zen in liquid nitrogen. The frozen mucosa was pulverized
with a mortar and added into 6 ml PBS containing 1% for-
maldehyde. The fixation was stopped after 30 min. by
adding glycine to a final concentration of 0.125 M. The
fixed mucosa was pelleted and sonicated as described for
the Caco2 cells.
Immunoprecipitation
The immunoprecipitations and array promoter array anal-
yses were done in triplicates. For each immunoprecipita-
tion, 300 μL of crosslinked sonicated sample was diluted
with 1.2 ml ChIP buffer (1% triton X-100, 150 mM NaCl,
2 mM EDTA, 20 mM Tris-HCl pH 8.1 and protease inhib-
itors (Sigma Aldrich)) and precleared for one hour by
adding 50 μL of protein A beads (50% slurry protein A-
Sepharose, Amersham; 0.5 mg/mL lipid-free BSA, (Sigma
Aldrich); and 0.2 mg/mL salmon sperm DNA in TE).
From each sample 15 μl, corresponding to 1% of the input
DNA, was removed for later use as input control. Samples
were immunoprecipitated overnight at 4°C with polyclo-
nal antibodies specific for either HNF-4α (4 μg, Santa
Cruz, Cat. no. sc-8987), HA (4 μg, Santa Cruz, Cat. no. sc-
805) or acetylated Histone H3 (10 μg, Upstate Biotech,
Cat. no. 06-599). Immune complexes from the Caco-2
chromatin were recovered by adding 50 μL of protein A
beads (50% slurry protein A-Sepharose, Amersham; 0.5
mg/mL lipid-free BSA, 0.2 mg/mL salmon sperm DNA in
TE) and incubated for two hours at 4°C. Immune com-
plexes from mouse small intestine were isolated using 50
μL of protein A magnetic beads (Dynal, Invitrogen). The
beads were washed twice in Wash Buffer 1 (0.1% SDS, 1%
Triton X-100, 0.1 Deoxycholate, 150 mM NaCl, 1 mM
EGTA, 2 mM EDTA, 20 mM Tris-HCl pH 8.0), twice in
Wash Buffer 2 (0.1% SDS, 1% Triton X-100, 0.1% Deoxy-
cholate, 500 mM NaCl, 1 mM EGTA, 2 mM EDTA, 20 mM
Tris-HCl pH 8.0), once in Wash Buffer 3 (0.25 M LiCl,
0.5% Deoxycholate, 0.5% NP-40, 0.5 mM EGTA, 1 mM
EDTA, 10 mM Tris-HCl pH 8.0), and twice in TE buffer.
The DNA was eluted by adding 300 μL elution buffer (1%BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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SDS and 0.1 M NaHCO3, 200 mM NaCl) and incubated
for 30 minutes on a heat block at 65°C. The cross links
were reversed by incubation overnight at 65°C. The eluted
material was phenol-extracted and ethanol-precipitated.
The DNA was resuspended in 20 μL of water.
ChIP-chip analysis
The immunoprecipitated and input DNA was amplified
using ligation-mediated PCR [41]. The amplified ChIP
DNA was sent to NimbleGen Systems Inc. for labeling and
hybridization to a 1.5 kb promoter array containing
probes covering the region from -1350 to +150 of 24,275
human genes. (See http://www.nimblegen.com/prod
ucts/chip/index.html for a description of the promoter
array).
The data from the three HNF4α and three AcHis3 pro-
moter array analyses were extracted according to standard
operating procedures by NimbleGen Systems Inc. The
enrichment of HNF4α IP DNA was calculated as log2 ratio
between the HNF4α IP DNA and the genomic input DNA.
Mean enrichment ratios for HNF4α at each promoter were
calculated by using the five highest values located next to
each other in each promoter, as we found that a positive
signal typically expanded over five probes. The mean of
the three measurements of each promoter and p-values
for HNF4α enrichments (Student's t-test; ratios greater
than zero) were calculated. Promoters with p-values
below 0.05 and at least two-fold enrichments (log2 ratio
> 1) of the HNF4α IP DNA were regarded as potential
HNF4α target. 1541 promoters had a p-value < 0.05 and
a log2 ratio > 1. A list of these genes can be found in addi-
tional file 2. Furthermore a searchable Internet database
containing the ChIP-chip data from the HNF4α and
acetylated histone H3 data is available is available at
http://gastro.sund.ku.dk/chipchip/ and at NCBI's GEO
http://www.ncbi.nlm.nih.gov/sites/entrez?db=gds under
the series accession number: GSE7745.
ChIP qPCR analysis
Verification of enrichment due to immunoprecipitation
with HNF4α- and HA-antibody was done with real-time
PCR using the LightCycler (Roche) according to the man-
ufacturer's protocol with FastStart SYBR Green Master Mix
(Roche). Each PCR reaction generated only the expected
specific product, as shown by the melting-temperature
profiles of final products (dissociation curve, automati-
cally measured by the LightCycler instrument) and by gel
electrophoresis of test PCR reactions. The primers listed in
additional file 1 were used to amplify human genomic
sequences at HNF4α-target loci. Quantification of the
ChIP DNA was done using the method described by [42].
Electrophoretic mobility shift assay (EMSA)
Preparation of nuclear extracts and EMSAs were per-
formed as previously described [39]. For the competition
assays, 100-fold (2.5 pmol) excess of unlabeled probes
were added to the binding mixtures. 2 μg antibodies
against HNF4α sc-8987 (Santa Cruz Biotechnology) were
used in the supershift analyses. Oligonucleotides used are
listed in additional file 1.
Bioinformatics
The ChIP-chip data generated with the 1.5 kb promoter
array (NimbleGen) and the expression data generated
with the Human Genome U133 Plus 2.0 Array (Affyme-
trix) were coupled by using either accession number or
gene symbols provided by the manufacturers. About
2,000 genes that could not be coupled by accession
number or gene symbol were linked using the
GeneCruiser software http://genecruiser.broad.mit.edu/
genecruiser3/. Using these two methods, we were able to
link 14,650 NimbleGen promoters from a total of 24,124
promoters to the Affymetrix probesets (ProbeID).
In order to identify transcription factor binding sites over-
represented in the promoters that are up-regulated during
Caco-2 differentiation, promoter sequences from -1350 to
+150 were extracted using the UCSC Table browser http:/
/genome.ucsc.edu/. Over-represented transcription factor
binding sites were identified using the PRIMO software
http://gastro.sund.ku.dk/primoweb/[28], which is a faster
in-house version of the PRIMA software [43]. Promoters
enriched in binding to HNF4α were analyzed for tran-
scription factor binding site over-representation using the
same procedure (Table 1).
The functional terms (GO terms) from the Gene Ontology
were associated with promoters on the 1.5 kb promoter
array (NimbleGen) through Affymetrix's ProbeIDs and
GoSurfer software http://bioinformatics.bioen.uiuc.edu/
gosurfer/. GO terms containing a significant over-repre-
sentation of promoters with two fold HNF4α enrichment
in the ChIP-chip analysis were identified using Fishers
Exact Test, which was performed using the statistical com-
puting program package R http://cran.r-project.org/. GO
terms that were over-represented with a p-value less than
0.1 were included in the analysis. The full list of over-rep-
resented GO-terms can be found in additional file 3. A
processed list of over-represented GO-terms having posi-
tive signals for HNF4α binding in the ChIP-chip analysis
was produced (Table 2).
Results
In order to identify transcription factors of importance for
the differentiation of the intestinal epithelium, we ana-
lyzed the differentiation-dependent expression in Caco-2
cells. The Caco-2 cell line is well established as being one
of the best cell lines mimicking the in vivo differentiation
of enterocytes/colonocytes both morphologically and
biochemically [44]. RNA from undifferentiated and differ-
entiated Caco-2 cells were isolated and used to produceBMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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hybridization probes for an expression analysis using the
Human Genome U133 chip (Affymetrix). This was done
to identify the genes that are up-regulated during differen-
tiation. The promoter sequences from genes that were up-
regulated more than four times were extracted from the
UCSC Genome Bioinformatics Site and used to search for
transcription factor binding sites that are statistically over-
represented in these promoters. We have recently devel-
oped a program called PRIMO that combines the use of
transcription factor binding matrices to identify transcrip-
tion factor binding sites and Fishers Exact Test to analyze
for over-representations. The PRIMO analysis demon-
strated that up-regulated genes have an over-representa-
tion of HNF4α binding sequences or HNF4α-like
sequences (COUP-TF, PPAR) and GC-rich sequences
(Sp1, E2F, ETF) (Table 1).
An analysis of the level of HNF4α expression during dif-
ferentiation of Caco2 cells revealed that the HNF4α
mRNA level increases 7.8-fold during Caco-2 differentia-
Table 1: Analysis for over-representation of transcription factor binding sites using the PRIMO
HNF4α ChIP-chip data Caco2 mRNA expression data
Acc. No1 Transcription factor Hits2 P-value Hits2 P-value
M00411 HNF-4alpha1 (3161,18621,452,1089) 1.3E-43 (3296,18493,317,1217) 1.1E-05
M00134 HNF-4 (3294,18488,453,1088) 1.7E-39 (3428,18361,319,1215) 2.2E-04
M00158 COUP-TF, HNF-4 (3343,18439,421,1120) 4.8E-28 (3439,18350,325,1209) 4.1E-05
M00803 E2F (10649,11133,984,557) 2.0E-27 (10787,11002,846,688) 1.0E-02
M00464 POU3F2 (2673,19109,59,1482) 9.6E-27 (2649,19140,83,1451) 2.4E-15
M00764 HNF-4 direct repeat 1 (3511,18271,418,1123) 5.0E-23 (3613,18176,316,1218) 3.8E-02
M00512 PPARG (2775,19007,340,1201) 1.5E-19 (2888,18901,227,1307) 1
M00196 Sp1 (8570,13212,777,764) 1.2E-14 (8580,13209,767,767) 2.5E-13
M00108 NRF-2 (2787,18995,321,1220) 1.6E-14 (2937,18852,171,1363) 1
M00932 Sp1 (8850,12932,795,746) 2.7E-14 (8875,12914,770,764) 2.9E-10
M00931 Sp1 (8375,13407,757,784) 1.1E-13 (8377,13412,755,779) 7.6E-14
M00762 PPAR, HNF-4, COUP, RAR (3936,17846,412,1129) 2.9E-13 (3999,17790,349,1185) 1.5E-02
M00025 Elk-1 (2235,19547,264,1277) 1.4E-12 (2340,19449,159,1375) 1
M00695 ETF (7391,14391,674,867) 6.9E-12 (7446,14343,619,915) 5.7E-04
M00933 Sp1 (9528,12254,828,713) 1.7E-11 (9544,12245,812,722) 2.1E-09
M00638 HNF-4alpha (2389,19393,271,1270) 5.5E-11 (2419,19370,241,1293) 7.5E-05
M00032 c-Ets-1(p54) (2633,19149,291,1250) 8.8E-11 (2730,19059,194,1340) 1
M00763 PPAR direct repeat 1 (3802,17980,387,1154) 1.8E-10 (3860,17929,329,1205) 1.5E-01
M00765 COUP direct repeat 1 (3324,18458,336,1205) 2.9E-08 (3390,18399,270,1264) 1
M00672 TEF (3512,18270,161,1380) 3.4E-07 (3512,18277,161,1373) 5.0E-07
M00341 GABP (3601,18181,347,1194) 2.4E-06 (3699,18090,249,1285) 1
M00287 NF-Y (3353,18429,327,1214) 2.6E-06 (3382,18407,298,1236) 3.8E-02
M00652 Nrf-1 (2721,19061,273,1268) 6.3E-06 (2790,18999,204,1330) 1
M00255 GC box (9746,12036,803,738) 1.1E-05 (9751,12038,798,736) 1.9E-05
M00430 E2F-1 (2322,19460,236,1305) 3.8E-05 (2369,19420,189,1345) 1
M00224 STAT1 (2188,19594,223,1318) 7.3E-05 (2246,19543,165,1369) 1
M00716 ZF5 (6120,15662,528,1013) 1.8E-04 (6167,15622,481,1053) 1
M00649 MAZ (9648,12134,782,759) 4.6E-04 (9670,12119,760,774) 4.6E-02
M00309 ACAAT (3028,18754,286,1255) 5.2E-04 (3056,18733,258,1276) 1
M00775 NF-Y (2771,19011,265,1276) 5.6E-04 (2793,18996,243,1291) 4.8E-01
M00008 Sp1 (7119,14663,593,948) 1.8E-03 (7071,14718,641,893) 8.1E-11
M00007 Elk-1 (2809,18973,258,1283) 1.4E-02 (2851,18938,216,1318) 1
M00225 STAT3 (2167,19615,206,1335) 1.7E-02 (2205,19584,168,1366) 1
M00778 AhR (891,20891,98,1443) 3.0E-02 (924,20865,65,1469) 1
M00084 MZF1 (4944,16838,419,1122) 3.4E-02 (4985,16804,378,1156) 1
Analysis for over-representation of transcription factor binding sites using the PRIMO program on the HNF4α target promoters (HNF4α ChIP-chip 
data), and on the promoters of genes that are up-regulated during intestinal cell differentiation (Caco-2 mRNA expression data).
1 Accession numbers are obtained from Transfac database http://www.biobase.de. 2 The numbers in the parentheses referrers to: The first number 
= transcription factor binding site (TFBS)-positive promoters in the background set of promoters on the NimbleGen promoter array. The second 
number = TFBS-negative promoters in the background set of promoters analyzed on the NimbleGen promoter array. The third number = TFBS-
positive promoters in the target set of promoters. The fourth number = TFBS-negative promoters in target set of promoters. The background set 
contains all promoters on the Nimblegen promoter array except the promoters represented in the target set. The target sets of promoters are 
promoters predicted to associate with HNF4α or promoters up-regulated during Caco-2 differentiation. P-value is calculated using Fisher's Exact 
test and Bonferroni correction for multiple testing.BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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tion in the Affymetrix Gene chip analysis (accessible at
http://www.ncbi.nlm.nih.gov/sites/entrez?db=gds; series
accession number: GSE7745). Also at the protein level a
significant increase in the HNF4α expression was detected
(Figure 1A). In order to investigate the role of HNF4α in
differentiated intestinal cells, three HNF4α ChIP-chip
analyses were performed on differentiated Caco-2 cells.
All promoters (from position +150 to -1350) are covered
by 15 50'mer oligonucleotide probes on the tiling pro-
moter array. The means of the five highest signals from




6869 (lipid transport)(N = 16 E = 9 p = 0.026)
15849 (organic acid transport)(N = 18 E = 10 p = 0.015)
48193 (Golgi vesicle transport)(N = 24 E = 15 p = 0.052)
15837 (amine transport)(N = 16 E = 8 p = 0.012)
6865 (amino acid transport)(N = 15 E = 7 p = 0.014)
8152 (metabolism)
44237 (cellular metabolism) (no)
6066 (alcohol metabolism)(N = 47 E = 32 p = 0.020)
51186 (cofactor metabolism) (no)
6732 (coenzyme metabolism)(N = 27 E = 19 p = 0.076)
9109 (coenzyme catabolic process)(N = 7 E = 3 p = 0.049)
6084 (acetyl-CoA metabolism)(N = 11 E = 3 p = 0.001)
6091 (generation of precursor metabolites and energy)(N = 92 E = 68 p = 0.007)
6118 (electron transport)(N = 59 E = 41 p = 0.009)
6119 (oxidative phosphorylation)(N = 14 E = 8 p = 0.049)
6082 (organic acid metabolism)(N = 80 E = 54 p = 0.001)
19752 (carboxylic acid metabolism)(N = 80 E = 54 p = 0.001)
9308 (amine metabolism)(N = 55 E = 43 p = 0.073)
6519 (amino acid and derivative metabolism)(N = 47 E = 35 p = 0.057)
6725 (aromatic compound metabolism) (no)
19439 (aromatic compound catabolism)(N = 6 E = 2 p = 0.008)
43170 (macromolecule metabolism) (no)
9059 (macromolecule biosynthesis)(N = 124 E = 83 p = 3.5E-05)
6259 (DNA metabolism)(N = 112 E = 80 p = 0.001)
51052 (regulation of DNA metabolism)(N = 10 E = 5 p = 0.039)
6323 (DNA packaging)(N = 46 E = 34 p = 0.054)
6325 (establishment and/or maintenance of chromatin architecture)(N = 46 E = 33 p = 0.034)
6310 (DNA recombination)(N = 18 E = 10 p = 0.027)
6281 (DNA repair)(N = 43 E = 29 p = 0.019)
6260 (DNA replication)(N = 30 E = 22 p = 0.079)
16070 (RNA metabolism)(N = 87 E = 65 p = 0.011)
6399 (tRNA metabolism)(N = 19 E = 10 p = 0.009)
6396 (RNA processing)(N = 69 E = 54 p = 0.051)
6519 (amino acid and derivative metabolism)(N = 47 E = 35 p = 0.057)
19538 (protein metabolism) (no)
6412 (protein biosynthesis)(N = 117 E = 75 p = 1.0E-05)
6418 (tRNA aminoacylation for protein translation)(N = 11 E = 5 p = 0.031)
6414 (translational elongation)(N = 7 E = 3 p = 0.034)
6457 (protein folding)(N = 44 E = 31 p = 0.028)
6629 (lipid metabolism)(N = 92 E = 70 p = 0.015)
6631 (fatty acid metabolism)(N = 27 E = 18 p = 0.040)
50790 (regulation of enzyme activity)
43086 (negative regulation of enzyme activity)(N = 14 E = 7 p = 0.025)
6469 (negative regulation of protein kinase activity)(N = 10 E = 5 p = 0.041)
45859 (regulation of protein kinase activity)(N = 25 E = 17 p = 0.088)
79 (regulation of cyclin dependent protein kinase activity)(N = 12 E = 5 p = 0.011)
6469 (negative regulation of protein kinase activity)(N = 10 E = 5 p = 0.041)
N is the number of identified HNF4α targets assigned with the GO-term indicated. E is the expected number of genes to be found in the GO 
category. p is the p-value from a Fisher Exact test for the over-representation of HNF4α target genes in the GO category. "no" indicates the higher 
level GO categories are not over-represented by HNF4α target genes. but contain lower level GO categories with over-representation. A full list 
of all GO categories with over-representation is presented in additional file 3BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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neighboring probes were used to calculate the mean
enrichment of HNF4α IP DNA over genomic DNA for
each promoter. Only promoters with significant enrich-
ments (p < 0.05), which were greater than two-fold, were
selected in order to limit the set of potential HNF4α target
promoters in our further analyses. 1541 promoters con-
tain signals fulfilling these two criteria (see additional file
2). This group contains several promoters that previously
have been shown to be regulated by HNF4α in liver (eg.
HNF1α, apolipoproteins, etc. [41]). The selected group of
potential HNF4α-target promoters have a significant over-
representation of HNF4α sites and HNF4α site-like
sequences (COUP-TF, PPAR, LEF1) when analyzed by the
PRIMO program. GA-rich binding sites (e.g. NRF-2,
GABP, Ets) and GC-rich binding sites (e.g. Sp1, E2F, ETF)
were also over-represented in the potential HNF4α-target
promoters However, we were not able to identify a
HNF4α binding site in 2/3 of promoters on the list of
potential HNF4α-target promoters, which could be due to
either an incomplete identification of the HNF4α binding
sites by PRIMO or because HNF4α bound to a region out-
side the arrayed region has caused isolation of the pro-
moter DNA in the ChIP through protein-protein
interactions.
An analysis of the position of the in silico identified
HNF4α sites revealed that many HNF4α sites are located
around the transcriptional start site, but a substantial
number of sites are also located further away from the
transcriptional start site, particularly around position -500
and -1000 bp (Figure 1B). The analysis of the location of
probes giving the ChIP-chip signals from the HNF4α anal-
ysis showed the same pattern which is in contrast to the
ChIP-chip signals from acetylated histone H3 analysis
that are mainly found in the transcribed region (+1 to
+150) and the regions around -300 (Figure 1C and 1D).
To identify pathways and functions regulated by HNF4α,
we investigated the functional gene ontology (GO) terms
that have been assigned to the potential HNF4α-target
genes (Table 2). We found that three high-level GO-terms
(GO:51179:localization; GO:8152:metabolism;
GO:50790:regulation of enzyme activity) contained most
of the GO-terms that have an over-representation of
HNF4α-target genes. In the group of GO-terms under
"localization", we found that genes categorized under the
terms lipid transport (GO:6869) and amino acid trans-
port (GO:6865) were over-represented. In the "metabo-
lism" group several GO-terms were over-represented: e.g.,
amino acid metabolism, lipid metabolism, and DNA and
RNA metabolism. In the group "regulation of enzyme
activity", "regulation of protein kinase activity" was over-
represented. It can be concluded that the HNF4α regulates
expression of genes that are essential for the function of
the enterocyte: for example, final absorption of nutrients
(lipid and amino acid transport and metabolism).
Intestinal HNF4α-target genes
We selected three promoters for further thorough investi-
gation because they represented different categories of tar-
gets for HNF4α regulation.
Cdx-2 (CDX2)
Interestingly, the ChIP-chip study revealed that the pro-
moter for the intestine-specific transcription factor Cdx-2
is bound by HNF4α. Clear signals from probes located at
positions -206, -286, -356, and -486 in the Cdx-2 pro-
moter were retrieved (Figure 2B). The histones on the
chromatin of the Cdx-2 gene are furthermore acetylated
after the transcriptional start site, indicating that the pro-
moter is transcriptionally active. This data indicates that a
HNF4α protein level, predicted binding sites and ChIP-chip  results for HNF4α and acHis3 Figure 1
HNF4α protein level, predicted binding sites and 
ChIP-chip results for HNF4α and acHis3. A) Western 
Blot of HNF4α and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) in nuclear extracts from undifferentiated and 
differentiated Caco2 cells. B) Distribution of HNF4α binding 
sites. The positions of HNF4α binding sites were determined 
in promoters of genes that are up-regulated during differenti-
ation of Caco-2 cells using the M00411 matrix from the 
Transfac database http://www.biobase.de/ and the PRIMO 
program http://gastro.sund.ku.dk/primo/. The number of 
HNF4α hits (Y-axis) was determined in 100 bp intervals from 
position -1350 to +150 (X-axis). C) Distribution of probes 
giving a positive signal (> two-fold enrichment) in the HNF4α 
ChIP-chip analysis. D) Distribution of probes giving a positive 
signal (>four-fold enrichment) in the acetylated histone H3 
ChIP-chip analysis.BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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transcriptional link exists between HNF4α and Cdx-2. The
HNF4α binding to the Cdx-2 promoter was verified by
ChIP qPCR analysis using primers covering the HNF4α
positive region (Figure 2C). A HNF4α consensus sequence
is located at position -358 to -340 (Figure 2A). In order to
identify whether the ChIP signals originated from this
HNF4α site, we performed a supershift analysis using a
probe covering the HNF4α site and nuclear extract from
differentiated Caco-2 cells (Figure 2D). Two specific com-
plexes are formed with the probe. One of them is super-
shifted with an antibody against HNF4α, demonstrating
the presence of HNF4α in this complex. To further func-
tionally validate the role of HNF4α in the regulation of
Cdx-2 expression, we performed a promoter study of the
region -1212 to +36. This region of the promoter was
cloned in front of the luciferase reporter gene both as
wildtype and with mutations abolishing the HNF4α bind-
ing (Figure 2D, lane 3).
The Cdx-2 promoter constructs were used to transfect the
intestinal epithelial cell line Caco-2 and COS7 cells, a cell
line without detectable HNF4α expression and previously
used to study the effect of HNF4α on promoter activity
[45,46]. The Cdx-2 promoter was able to drive a higher
reporter gene expression in Caco-2 compared to COS7
cells. Over-expression of HNF4α significantly increased
the reporter gene expression in both Caco-2 and COS7
cells, and mutation of the HNF4α site significantly
reduced the reporter gene expression in Caco-2 cells to the
basic level observed in COS7 cells (Figure 2E).
Trehalase (TREH)
The trehalase promoter is another interesting promoter
that is on the list of potential HNF4α-target genes (see
additional file 2). Trehalase is a brush border disacchari-
dase that hydrolyses trehalose, mainly found in fungi, to
glucose [47]. Trehalase has a very restricted expression
pattern, as it is only expressed in the mature enterocytes in
the small intestine after weaning and in the kidney [48].
Trehalase is therefore regarded as a specific marker for the
terminally differentiated enterocyte.
An HNF4α ChIP-enrichment was detected by the probes
in positions +14, -46, -66, -96, and -186 (Figure 3B). In
this region we also found a significant histone acetylation.
A predicted HNF4α binding site is located at position -50
to -38, and a ChIP qPCR analysis of the region confirmed
the HNF4α interaction with this region (Figure 3C). A
supershift analysis clearly demonstrated a strong specific
HNF4α binding to the predicted HNF4α site (Figure 3D),
and a functional reporter gene analysis of the trehalase
promoter in Caco-2 and COS7 cells showed that the tre-
halase promoter is strongly influenced by both HNF4α
over-expression and by mutations in the HNF4α binding
site (Figure 3E). The results point toward a strong involve-
ment of the HNF4α in the regulation of trehalase expres-
sion.
Cingulin (CGN)
The function of cingulin is presently not fully understood,
but the cingulin protein has been reported to be present
in tight junctions interacting with the tight junction pro-
tein ZO-1 [49]. The involvement of cingulin in tight junc-
tion formation prompted us to further investigate the
regulatory role of HNF4α in cingulin expression, as tight
junction formation is an important event in the differen-
tiation of the enterocyte and the establishment of the bar-
rier between the intestine and the intestinal lumen. The
ChIP-chip analysis revealed a binding of HNF4α to the
region from -1264 to -924 in the cingulin promoter (Fig-
ure 4B). This binding was confirmed by ChIP qPCR (Fig-
ure 4C). We also found that the chromatin of the cingulin
promoter is histone H3-acetylated. However, the acHis3
signal does not directly overlap the HNF4α signal (Figure
4B).
A potential HNF4α binding site is located at position -
1202 to -1189 (Figure 4A). EMSA demonstrated that this
site specifically forms a protein/DNA complex that is
supershifted by a HNF4α antibody (Figure 4D). Muta-
tions in the HNF4α site reduced the promoter activity in
Caco-2 cells, and over-expression of HNF4α increased the
promoter activity in Caco-2 cells, however in COS7 cells
the reporter gene expression is only slightly influenced by
HNF4α over-expression (Figure 4E). The over-expression
results demonstrate that HNF4α plays a role in regulating
cingulin expression, but other transcription factors are
important for the activation of the cingulin gene, which
are not expressed in COS7 cells. The mutation of the
HNF4α site reduces the cingulin promoter activity in
Caco-2 cells to the basic level observed in COS7 cells.
In vivo binding of HNF4α in mouse small intestine
In order to further verify the HNF4α binding to the Cdx-
2, trehalase, and cingulin promoters in vivo, ChIP analyses
were performed on mouse small intestinal mucosa (figure
5). As positive controls HNF4α (Tcf1), apolipoprotein
CIII (Apoc3), and phosphoenolpyruvate carboxykinase 1
(Pck1) were also included in the analysis as these genes
have been reported to be HNF4α targets in the mouse
liver[50] and were on our list of potential HNF4α targets
in Caco-2 cells (see additional file 2). HNF1α, Apoc3, and
Pck1 promoters were all significantly enriched for HNF4α
IP DNA, as well as Cdx2 and trehalase. However, the
HNF4α ChIP analysis of the cingulin promoter did not
reveal a binding of HNF4α in the mouse small intestine.
Discussion
The HNF-transcription factors are recognized as being
central factors in the regulation of liver- and pancreas-spe-BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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Analysis of the CDX2 promoter Figure 2
Analysis of the CDX2 promoter. A) The promoter region cloned in pGL4.10. The coordinates are relative to +1, the tran-
scriptional start site. The arrows indicate primers used in the real-time qPCR. The possible HNF4α binding site and the 
mutated sequence is shown below. B) HNF4α ChIP-chip and AcHis3 ChIP-chip results for probes spanning the CDX2 pro-
moter. Enrichments are shown as Log2 ratios between immunoprecipitated and input DNA. N = 3. C) Real-time qPCR with 
CDX2 and IgG intron primers using HNF4α ChIP, HA ChIP and input DNA. Enrichments are presented as percent of total 
input. N = 4. The CDX2 promoter enrichment is statistical significant (p-values < 0.05, Student T test). D) Gel shift analysis of 
the HNF4α site in the CDX2 promoter using Caco-2 nuclear extract (lane 1). Competition by unlabelled wt (lane 2), mut-
HNF4α oligonucleotides (lane 3) and an unrelated oligonucleotide (lane 4) demonstrating a specific binding. One of the two 
protein/DNA bands can be supershifted with HNF4α antibody (lane 5). E) Promoter analysis of CDX2 promoter in Caco-2 
(grey bars) and COS7 (white bars) cells with and without co-transfection of HNF4α expression plasmid. The binding site for 
HNF4α was mutated in order to analyze the functional importance of the HNF4α site (pGL4-CDX2 mutHNF4). The luciferase 
activity was corrected for transfection efficiency and normalized to the expression of pGL4-CDX2, N = 4.BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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Analysis of the trehalase (TREH) promoter Figure 3
Analysis of the trehalase (TREH) promoter. A) Map of the TREH promoter region. PCR primers, the HNF4α binding site, 
and the mutations are shown. B) HNF4α ChIP-chip and AcHis3 ChIP-chip results for probes spanning the TREH promoter. N 
= 3. C) Real-time qPCR analysis of HNF4α ChIP, HA ChIP and input DNA using TREH and IgG intron primers. N = 3. The 
TREH promoter enrichment is statistical significant (p-values < 0.05, Student T test). D) Gel shift analysis of the HNF4α site in 
the TREH promoter. E) Promoter analysis of the TREH promoter in Caco-2 (grey bars) and COS7 (white bars) cells with and 
without co-transfection of HNF4α expression plasmid and a mutation in the HNF4α site (pGL4-TREH mutHNF4). The luci-
ferase activity was corrected for transfection efficiency and normalized to the expression of pGL4-TREH, N = 4.BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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Analysis of the cingulin (CGN) promoter Figure 4
Analysis of the cingulin (CGN) promoter. A) Map of the CGN promoter region. PCR primers, the HNF4α binding site, 
and the mutations are shown. B) HNF4α ChIP-chip and AcHis3 ChIP-chip results for probes spanning the CGN promoter. N 
= 3. C) Real-time qPCR analysis of HNF4α ChIP, HA ChIP and input DNA using CGN and IgG intron primers. N = 3. The CGN 
promoter enrichment is statistical significant (p-values < 0.05, Student T test). D) Gel shift analysis of the HNF4α site in the 
CGN promoter. E) Promoter analysis of the CGN promoter in Caco-2 (grey bars) and COS7 (white bars) cells with and without 
co-transfection of HNF4α expression plasmid and a mutation in the HNF4α site (pGL4-CGN mutHNF4). The luciferase activ-
ity was corrected for transfection efficiency and normalized to the expression of pGL4-CGN, N = 4.BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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cific genes. Odom et al. (2004) performed ChIP-chip
analysis of HNF1α, HNF4α, and HNF6 in hepatocytes
and pancreatic islets and found that HNF4α was bound to
12% of the genes in hepatocytes and 11% in pancreatic
islets. We have found that 11% of the genes that are up-
regulated in the gene expression array analysis during dif-
ferentiation have a two-fold enrichment of HNF4α IP
DNA in the ChIP-chip of the Caco-2 cells and the bioin-
formatic analyses showed that HNF4α binding sites are
significantly over-represented in promoters that are up-
regulated during Caco-2 differentiation (table 1). We have
previously analyzed intestinal differentiation in mice and
identified HNF4α as a regulator of differentiation-
induced transcription [28]. These results support the sug-
gestion that HNF4α is a central player in the differentia-
tion-induced expression of genes in the gastrointestinal
tract [28,30,41].
By assigning biological functions (GO-terms) to the
HNF4α target genes, we have identified that HNF4α target
genes are over-represented in the GO-terms related to
lipid and amino acid transport and metabolism. Absorp-
tion of nutrients is one of the main functions of the small
intestinal epithelium. It is notable that HNF4α binds to
many apolipoprotein promoters (see the ChIP-chip data-
base: http://gastro.sund.ku.dk/chipchip/; search term =
apoliprotein). The HNF4α regulation of many genes
involved in metabolism agrees with the notion that the
transcriptional activity of HNF4α is regulated by AMP-
activated protein kinase, the central component of a cellu-
lar signaling system that regulates many metabolic
enzymes and pathways in response to reduced intracellu-
lar energy levels [34].
Another important role of the enterocytes is the final
hydrolysis of oligopeptides to dipeptides and amino acids
by the membrane-bound brush border peptidases. Our
ChIP-chip analysis shows that several of the important
brush border peptidases can be expected to be regulated
by HNF4α: e.g., aminopeptidase N (ANPEP), which is one
of the most abundant proteins in the brush border. A 4.3-
fold enrichment of HNF4α IP DNA on aminopeptidase N
promoter was found and the aminopeptidase N mRNA
expression is up-regulated 32-times during Caco-2 differ-
entiation (see additional file 2). We have previously stud-
ied the aminopeptidase N promoter in detail[16,28,51-
53] and have identified a COUP/HNF4α binding site,
which is important for epithelial expression. We originally
suggested that the site interacts with the COUP transcrip-
tion factor [52]. However, as COUP and HNF4α have
overlapping binding specificities, we find it likely that
HNF4α binds to the COUP/HNF4α element.
Expression of disaccharidases in the brush border mem-
brane is a unique characteristic of the enterocytes. Disac-
charidase expression is not found in the liver or in the
pancreas. The expression of sucrase-isomaltase (SI),
lactase-phlorizin hydrolase (LCT), trehalase (TREH), and
maltase-glucoamylase (MGAM) are necessary for digest-
ing sucrose, lactase, trehalose, and maltose, respectively,
and deficiency in the expression of any of these enzymes
results in severe digestive problems [54,55]. We have pre-
viously described that the lactase-phlorizin hydrolase pro-
moter activity is regulated by HNF4α through binding to
an enhancer located 13910 bp from the promoter [56].
This region was not analyzed in ChIP-chip, but we found
a significant binding to the trehalase promoter in ChIP-
HNF4α ChIP on mouse small intestinal epithelium Figure 5
HNF4α ChIP on mouse small intestinal epithelium. 
Chromatin immunoprecipitation analysis of HNF4α binding 
to HNF1α (Tcf1), phosphoenolpyruvate carboxykinase 1 
(Pck1), apolipoprotein C3 (Apoc3), Cdx-2 (Cdx2), trehalase 
(Treh), and cingulin (Cgn) promoters in mouse small intestinal 
epithelium. An intron in the IgG gene served as a negative 
control (IgG). The analyzed promoter regions are all con-
served between human and mouse. Enrichments are repre-
sented as percent of the total amount of genomic input DNA 
in ChIP. Significant enrichments are indicated (p-values < 
0.001 is shown by ***, p-values < 0.05 is shown by *).BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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chip analysis (Figure 3B), which was verified by ChIP-
qPCR in both Caco-2 cells (Figure 3C) and mouse small
intestinal mucosa (Figure 5). EMSA and promoter analy-
ses of the trehalase promoter further demonstrate that
HNF4α binds and regulates the trehalase promoter activ-
ity (Figure 3DE). These results show that HNF4α is
involved in regulating dissacharidase expression specific
to the small intestinal epithelium.
The differentiation of the absorptive intestinal cell (ente-
rocyte/Caco-2) is accomplished by a remarkable pheno-
typic change. During differentiation the enterocyte
becomes polarized with tight junctions and a brush bor-
der membrane with a highly specialized content of diges-
tive enzymes. HNF4α seems to directly regulate some of
the genes involved in this process. For example, cingulin
is a tight junction associated protein that we find is regu-
lated by HNF4α in Caco-2 cells [49]. We have not, how-
ever, been able to demonstrate HNF4α binding to the
mouse cingulin promoter in the small intestinal mucosa,
which indicates that either HNF4α is not regulating cingu-
lin in the mouse or that an HNF4α binding site in the
mouse cingulin promoter is located outside the investi-
gated region. Interestingly, it has recently been found that
more genes are regulated by HNF4α in human liver than
in mouse [50]. Only 1/3 of the HNF4α bound human
promoter genes were also found in mouse. Thus, based on
our EMSA and ChIP results on the Caco-2 cells we sug-
gested that the cingulin is a bona fide HNF4α target gene
in Caco-2 cells. Other tight junction proteins, claudins
(CLDN2[27]), are on the list of potential HNF4α-target
genes. The findings of HNF4α controlling the expression
of genes involved in morphological differentiation
become even more important when interpreted with the
finding by Peignon et al where E-cadherin is shown to
control the nuclear abundance of HNF4α [57]. This could
place HNF4α as an important link between the changes in
morphology and gene expression during differentiation
of intestinal cells.
As HNF4α could have a specific role in intestinal expres-
sion which is different from its role in the hepatocytic and
pancreatic expression, we sought for HNF4α target genes
that are specifically involved in intestinal development. A
search in the ChIP-chip data for transcription factors that
could be linked to HNF4α regulation revealed that
HNF4α binds to the Cdx-2 promoter. Cdx-2 plays a fun-
damental role in the mammalian embryonic develop-
ment. It controls the specification of the trophectoderm
lineage, the first differentiation event after fertilization of
the egg [58], and the anteroposterior patterning and pos-
terior axis elongation [59]. However, in adult mammals
the Cdx-2 expression is restricted to the small and large
intestine [36,60]. Our functional analyses show that
HNF4α regulates Cdx-2 promoter activity in Caco-2 (fig-
ure 2). This is supported by the enrichment of HNF4α IP
DNA to the Cdx-2 promoter in the ChIP qPCR analysis of
the mouse small intestinal mucosa (figure 5). In support
of our finding Benahmed et al. (2008) have shown that
HNF4α is involved in the regulation of the mouse Cdx-2
gene transcription [61]. In order to further validate the
importance of HNF4α for the Cdx-2 promoter activity, we
have, however unsuccessfully, tried to inhibit the HNF4α
activity by RNAi (transfection with HNF4α shRNA plas-
mids and siRNA) and by overexpression of a dominant
negative version of HNF4α [62] in Caco-2 cells (personal
data). The reduced HNF4α level seems to cause a poor
attachment of the cells to the culture disc suggesting that
alterations of the cell-cell or cell-substratum interactions
have occurred. Similar problems have previously been
reported when Caco-2 cells with reduced Cdx-2 expres-
sion were produced [63]. Ablation of the HNF4α gene in
fetal mouse colon resulted in failure to produce normal
crypts and influencing the expression of several intesti-
nally expressed genes [27]. A comparison of these genes
with our ChIP-chip data revealed HNF4α ChIP signals in
the promoters of SULT1B and MUCDHL genes, thus veri-
fying the results by Garrison et al., 2008. However, other
reported HNF4α target promoters (ALDOB, APOC2,
Table 3: Summary of the evidence for HNF4α regulation of intestinally expressed genes
Gene (Gene symbol) mRNA up-regulation during1 ChIP-chip2 ChIP q-PCR3 ChIP q-PCR3
Caco-2 differentiation Caco2 Caco2 Mouse
Cdx-2 (CDX2) 3.0 5.0 1.9 2.9
Trehalase (TREH) 3.5 4.1 1.9 3.2
Cingulin (CGN) 3.1 4.9 4.3 0.3
Apolipoprotein CIII (APOC3)9 . 9 5 . 3 N A 3 . 9
HNF1α (TCF1)1 . 6 4 . 7 N A 6 . 2
Phosphoenolpyruvate 7.7 5.6 NA 4.4
carboxykinase 1 (PCK1)
1Fold up-regulation of mRNA during Caco2 cell differentiation. Data were obtained from gene array expression analysis of undifferentiated and differentiated 
Caco2 cells.2ChIP-chip enrichment of HNF4α target DNA compared to genomic DNA. The data are presented as fold enrichments between HNF4α 
immunoprecipitated DNA and genomic DNA. 3q-PCR analysis of the HNF4α immunoprecipitated DNA shown as fold enrichment of the HNF4α IP DNA 
compared to genomic DNA (IgG intron). Array data can be downloaded from NCBI's GEO http://www.ncbi.nlm.nih.gov/sites/entrez?db=gds under the series 
accession number: GSE7745.BMC Gastroenterology 2009, 9:68 http://www.biomedcentral.com/1471-230X/9/68
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MUC3, SLC39A[27]) were unfortunately not represented
by probes in the promoter regions on the Nimblegen pro-
moter array and these promoters were therefore not
included in the ChIP-chip analysis.
Several intestinal expressed genes are regulated by a com-
bination of Cdx-2 and HNF1α: e.g., sucrase-isomaltase
[4,13] and lactase-phlorizin hydrolase [3,64]. It is well
known that a transcriptional circuit exists between
HNF1α and HNF4α in liver, as the HNF1α promoter is a
target for HNF4α regulation and HNF1α regulates the
HNF4α expression [41].
Conclusion
The HNF4α ChIP-chip analysis of differentiated Caco-2
cells has substantiated the role of HNF4α as a key tran-
scription factor in the differentiation-dependent regula-
tion in intestinal epithelial cells. Based on our results
(table 3), we suggest that HNF4α is a transcriptional node
that is involved in the maintenance of the network of tran-
scription factors (Cdx-2 and HNF1α) in intestinal epithe-
lial cells (Figure 6) although additional factors are
necessary to specify the intestinal specific expression. In
combination with the other members of the network,
HNF4α regulates expression of the genes that give the
intestinal cell its unique biochemical and physiological
features: e.g., trehalase and cingulin. In future studies it
would be very interesting to examine the role of HNF4α
in the initiation of the differentiation process
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A model of some of the components in an HNF4α regulated  transcription factor network regulating intestinal expression  of genes during cellular differentiation Figure 6
A model of some of the components in an HNF4α 
regulated transcription factor network regulating 
intestinal expression of genes during cellular differen-
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